Premium
Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision
Author(s) -
FuchsBuder T.,
Claudius C.,
Skovgaard L. T.,
Eriksson L. I.,
Mirakhur R. K.,
VibyMogensen J.
Publication year - 2007
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.2007.01352.x
Subject(s) - medicine , pharmacodynamics , neuromuscular blocking agents , blocking (statistics) , clinical practice , engineering ethics , pharmacology , family medicine , anesthesia , engineering , pharmacokinetics , statistics , mathematics
The set of guidelines for good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, which was developed following an international consensus conference in Copenhagen, has been revised and updated following the second consensus conference in Stockholm in 2005. It is hoped that these guidelines will continue to help researchers in the field and assist the pharmaceutical industry and equipment manufacturers in enhancing the standards of the studies they sponsor.